A Triterpenoid Inhibited Hormone-Induced Adipocyte Differentiation and Alleviated Dexamethasone-Induced Insulin Resistance in 3T3-L1 adipocytes
Tóm tắt
6α-Hydroxylup-20(29)-en-3-on-28-oic acid (1), a natural triterpenoid, was found to possess the ability in a dose-dependent manner inhibiting hormone-induced adipocyte differentiation in 3T3-L1 preadipocytes, and restoring glucose consuming ability in dexamethasone (DXM)-induced insulin resistant 3T3-L1 adipocytes. Compound 1 was also found to ameliorate DXM-induced adipocyte dysfunction in lipolysis and adipokine secretion. Mechanistic studies revealed that 1 inhibited adipocyte differentiation in 3T3-L1 preadipocytes via down-regulating hormone-stimulated gene transcription of peroxisome proliferator-activated receptor γ and CCAAT-enhancer-binding protein alpha which are key factors in lipogenesis, and restored DXM-impaired glucose consuming ability in differentiated 3T3-L1 adipocytes via repairing insulin signaling pathway and activating down-stream signaling transduction by phosphorylation of signaling molecules PI3K/p85, Akt2 and AS160, thus leading to increased translocation of glucose transporter type 4 and transportation of glucose.
Tài liệu tham khảo
L. Webber, D. Divajeva, T. Marsh, K. McPherson, M. Brown, G. Galea, J. Breda, BMJ Open 4, e004787 (2014)
M.D. DeBoer, Nutrition 29, 379–386 (2013)
S. Bhattacharya, D. Dey, S.S. Roy, J. Biosci. 32, 405–413 (2007)
M.P. Mattson, Exp. Gerontol. 44, 625–633 (2009)
J.J. Cao, J. Orthop. Surg. Res. 6, 30–36 (2011)
C.J. Shu, C. Benoist, D. Mathis, Semin. Immunol. 24, 436–442 (2012)
B. Antuna-Puente, B. Feve, S. Fellahi, J.P. Bastard, Diabetes Metab. 34, 2–11 (2008)
D.E. James, R.C. Piper, J. Cell Biol. 126, 1123–1126 (1994)
X. Gao, Y.J. Hu, L.C. Fu, Chin. J. Chin. Mat. Med. 32, 323–326 (2007)
J. Wu, W. Peng, R. Qin, H. Zhou, Molecules 19, 1685–1712 (2014)
J.Z. Ma, X.W. Yang, J.J. Zhang, X. Liu, L.L. Deng, X.L. Shen, G. Xu, Nat. Prod. Bioprospect. 4, 175–180 (2014)
K. Sarjeant, J.M. Stephens, Cold Spring Harb. Perspect. Biol. 4, a008417 (2012)
N. Moustaïd, H.S. Sul, J. Biol. Chem. 266, 18550–18554 (1991)
H. Sakoda, T. Ogihara, M. Anai, M. Funaki, K. Inukai, H. Katagiri, Y. Fukushima, Y. Onishi, H. Ono, M. Fujishiro, M. Kikuchi, Y. Oka, T. Asano, Diabetes 49, 1700–1708 (2000)
J. Burén, H.X. Liu, J. Jensen, J.W. Eriksson, Eur. J. Endocrinol. 146, 419–429 (2002)
R. Monteiro, I. Azevedo, Mediat. Inflamm. 2010, 289645 (2010)
I. Nieto-Vazquez, S. Fernández-Veledo, C. de Alvaro, M. Lorenzo, Diabetes 57, 3211–3221 (2008)
M. Lorenzo, S. Fernández-Veledo, R. Vila-Bedmar, L. Garcia-Guerra, C. De Alvaro, I. Nieto-Vazquez, J. Anim. Sci. 86, E94–E104 (2008)
H. Kwon, J.E. Pessin, Front. Endocrinol. 4, 71 (2013)
T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, K. Tob, J. Clin. Invest. 116, 1784–1792 (2006)
F. Ziemke, C.S. Mantzoros, Am. Clin. Nutr. 91, 258S–261S (2010)
A. Stofkova, Endocr. Regul. 43, 157–168 (2009)
S. Huang, M.P. Czech, Cell Metab. 5, 237–252 (2007)
V.T. Samuel, K.F. Petersen, G.L. Shulman, Lancet 375, 2267–2277 (2010)
R.T. Watson, J.E. Pessin, Cell. Signal. 19, 2209–2217 (2007)
S.X. Tan, Y. Ng, J.G. Burchfield, G. Ramm, D.G. Lambright, D.E. James, Mol. Cell. Biol. 32, 4946–4959 (2012)
J.L. Ramírez-Zacarías, F. Castro-Muñozledo, W. Kuri-Harcuch, Histochemistry 97, 493–497 (1992)